Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Bradley J. Monk
ResearcherPublications, citations & collaboration network
Bradley J. Monk is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 1,000 works, 45,892 citations, an h-index of 94 and an i10-index of 427.
1,000
Works
45,892
Citations
94
h-index
427
i10-index
How has Bradley J. Monk's publication output changed over time?
ScholarIQpublication output · 2001–2023
Output grew0% over the shown period — from 1 works in 2001 to 1 in 2023.
1
1
1
1
1
2
1
1
1
1
2001200720092011201420162017201920212023
What are the most-cited papers on Bradley J. Monk?
ScholarIQmost cited works
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt, Amit M. Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A. Ledermann, Domenica Lorusso, Ignace Vergote, Noa Ben-Baruch, Christian Marth, Radosław Mądry, René dePont Christensen, Jonathan S. Berek, Anne Dørum, Anna V. Tinker, Andreas du Bois, Antonio González-Martı́n, Philippe Follana, Benedict B. Benigno, Per Rosenberg, Lucy Gilbert, B.J. Rimel, Joseph Buscema, John Balser, Shefali Agarwal, Ursula A. Matulonis
New England Journal of Medicine. 20162,477 CitationsOPEN ACCESS
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Robert A. Burger, Mark F. Brady, Michael A. Bookman, Gini F. Fleming, Bradley J. Monk, Helen Huang, Robert S. Mannel, Howard D. Homesley, Jeffrey M. Fowler, Benjamin E. Greer, Matthew Boente, Michael J. Birrer, Sharon X. Liang
New England Journal of Medicine. 20112,398 CitationsOPEN ACCESS
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
William A. Peters, P.Y. Liu, Rolland J. Barrett, Richard J. Stock, Bradley J. Monk, Jonathan S. Berek, Luís Souhami, Perry W. Grigsby, William Gordon, David S. Alberts
Journal of Clinical Oncology. 20002,333 CitationsOPEN ACCESS
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Antonio González-Martı́n, Bhavana Pothuri, Ignace Vergote, René dePont Christensen, Whitney A. Spannuth Graybill, Mansoor R. Mirza, Colleen McCormick, Domenica Lorusso, Paul Hoskins, Gilles Freyer, Klaus Baumann, К. Jardon, Andrés Redondo, Richard G. Moore, Christof Vulsteke, Roisin E. O’Cearbhaill, Bente Lund, Floor Backes, Pilar Barretina-Ginesta, Ashley Haggerty, María Jesús Rubio-Pérez, Mark S. Shahin, Giorgia Mangili, William H. Bradley, Ilan Bruchim, Kaiming Sun, Izabela A. Malinowska, Yong Li, Divya Gupta, Bradley J. Monk
New England Journal of Medicine. 20192,291 CitationsOPEN ACCESS
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari, Michael W. Sill, Harry J. Long, Richard T. Penson, Helen Huang, Lois M. Ramondetta, Lisa M. Landrum, Ana Oaknin, Thomas Reid, Mario M. Leitão, Helen E. Michael, Bradley J. Monk
New England Journal of Medicine. 20141,512 CitationsOPEN ACCESS
Related on ScholarIQ
Florida Cancer Specialists & Research Institute
Institution
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Paper
Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
Paper
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
Paper
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Paper
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Paper